Hair Care
GLP-1 Drugs and Bone Density
Studies on GLP-1 medication and bone health genuinely disagree with each other. Here is why, and what that means for any...
This is the technical concept underlying everything covered in our guides to sublingual absorption and injections vs drops. Understanding it precisely explains why delivery route makes such a large practical difference for certain compounds.
What bioavailability actually measures
Bioavailability is the fraction of an administered dose that reaches systemic circulation in active form, expressed as a percentage.
An intravenous injection, delivering a compound directly into the bloodstream, is the reference point at 100 percent bioavailability by definition, since nothing is lost between administration and circulation.
Every other route loses some fraction along the way, and how much varies enormously depending on the compound and the route.
Why oral bioavailability is often low for peptides
Semaglutide, the molecule in Ozempic and Wegovy, is a peptide, a chain of amino acids. Swallowed peptides face two major obstacles.
Digestive breakdown. Enzymes in your stomach and intestine are specifically designed to break proteins and peptides into smaller pieces for absorption as nutrients, which destroys the peptide's intended structure and function before it can act as a drug.
First-pass liver metabolism. Whatever survives digestion and is absorbed in the intestine travels first to the liver via the portal vein, where it undergoes further processing before reaching general circulation. This can substantially reduce the active amount that ultimately reaches your bloodstream.
Together, these factors mean oral peptide bioavailability is often in the low single digits as a percentage, without specific formulation strategies to improve it.
Why Rybelsus needs such a large relative dose
This directly explains something covered in our guide to Rybelsus side effects.
Oral semaglutide is formulated with an absorption enhancer specifically designed to improve bioavailability, and it must be taken on an empty stomach with minimal water to maximise the (still modest) fraction absorbed.
Even with this formulation strategy, the oral bioavailability of semaglutide remains considerably lower than the injectable form, which is precisely why oral doses are set higher in milligram terms than injectable doses, to compensate for the fraction lost, and why the empty-stomach protocol matters so much: it exists to protect what little absorption efficiency the formulation achieves.
Why sublingual bioavailability is typically higher
Sublingual absorption avoids both major obstacles facing swallowed compounds.
No digestive exposure. The compound crosses the oral mucosa directly rather than travelling through the stomach and intestine, so digestive enzyme breakdown does not apply in the same way.
Reduced first-pass metabolism. Blood vessels under the tongue drain toward general circulation through a route that substantially bypasses the initial liver processing that oral absorption undergoes.
This is why sublingual delivery is a genuinely different proposition from swallowing, bioavailability-wise, closer in principle to injection than to an oral tablet, even though it involves no needle.
What this means for comparing products
This is the practically useful takeaway.
A specific milligram number on a label means little without knowing the bioavailability of that specific formulation and route. A higher milligram dose delivered through a low-bioavailability route can deliver less active compound to your bloodstream than a lower milligram dose delivered through a higher-bioavailability route.
This is why direct milligram comparisons between an injectable, an oral tablet, and a sublingual product are not meaningful without understanding what fraction of each dose actually reaches circulation.
Where this connects to what METASLIM offers
GLP-1 pathway support delivered as drops uses sublingual delivery specifically because of the bioavailability advantage this mechanism provides over swallowing. METASLIM™ is a physician-reviewed sublingual supplement, and its formulation and dosing account for the sublingual route's absorption characteristics, distinct from a pharmaceutical GLP-1 receptor agonist like semaglutide, so STEP 1 results describe that specific injectable pharmaceutical rather than this product.
The summary
Bioavailability measures the fraction of a dose that reaches your bloodstream intact, with intravenous injection as the 100 percent reference point.
Swallowed peptides face digestive breakdown and first-pass liver metabolism, often reducing oral bioavailability to low single digits without specific formulation help.
This is why Rybelsus uses a much higher milligram dose than the injectable form, and why its empty-stomach protocol matters so much for protecting the limited absorption it achieves.
Sublingual delivery avoids both major obstacles, generally achieving higher bioavailability than swallowing for compounds that would otherwise be poorly absorbed orally.
Milligram doses are not directly comparable across different delivery routes without accounting for each route's bioavailability.
Check the current price and what's included for a product using sublingual delivery specifically for this reason.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.